Stocks and Investing
Stocks and Investing
Thu, June 16, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, June 15, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, June 14, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, June 13, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Newman Upgraded (AGIO) to Strong Buy and Increased Target to $90 on, Jun 13th, 2016
John Newman of Canaccord Genuity, Upgraded "Agios Pharmaceuticals, Inc." (AGIO) to Strong Buy and Increased Target from $50 to $90 on, Jun 13th, 2016.
John has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Debjit Chattopadhyay of "Janney Montgomery Scott" Initiated at Hold on, Wednesday, March 2nd, 2016
This is the rating of the analyst that currently disagrees with John
- Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $70 on, Wednesday, May 18th, 2016
Contributing Sources